Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,761 | 1,302 | 69,963 | 2,573 | 64,872 |
| Cost of Goods | N/A | N/A | 1,397 | 1,402 | 15,975 |
| Gross Profit | 1,761 | 1,302 | 68,566 | 1,171 | 48,897 |
| Operating Expenses | 6,521 | 9,825 | 67,772 | 81,150 | 205,413 |
| Operating Income | -4,760 | -8,523 | 1,191 | -79,577 | -155,541 |
| Interest Expense | 0 | 0 | 0 | 0 | 28,581 |
| Other Income | 2,417 | 781 | -117 | 272 | 598 |
| Pre-tax Income | -2,343 | -7,742 | 1,074 | -79,305 | -183,524 |
| Income Tax | -31 | -43 | N/A | N/A | N/A |
| Net Income Continuous | -2,312 | -7,699 | 1,074 | -79,305 | -183,524 |
| Net Income Discontinuous | 131 | -2,579 | 110,923 | -93,110 | N/A |
| Net Income | $-2,181 | $-10,278 | $111,997 | $-172,415 | $-183,524 |
| EPS Basic Total Ops | -0.19 | -0.99 | 12.41 | -21.66 | -33.50 |
| EPS Basic Continuous Ops | -0.20 | -0.74 | 0.12 | -9.96 | -33.29 |
| EPS Basic Discontinuous Ops | 0.01 | -0.25 | 12.29 | -11.70 | N/A |
| EPS Diluted Total Ops | -0.19 | -0.99 | 11.96 | -21.66 | -33.50 |
| EPS Diluted Continuous Ops | -0.20 | -0.74 | 0.11 | -9.96 | -33.29 |
| EPS Diluted Discontinuous Ops | 0.01 | -0.25 | 11.84 | -11.70 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.74 | -13.46 | -21.00 | -34.00 |
| EBITDA(a) | $-4,251 | $-7,601 | $2,384 | $-78,841 | $-151,474 |